Clinical trials
Lymphatic Metastasis trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
| Recruiting | 5 |
| Completed | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fifth Affiliated Hospital, Sun Yat-Sen University | 3 |
| Shanghai Zhongshan Hospital | 2 |
| Bin Cheng | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Huashan Hospital | 1 |
| Huazhong University of Science and Technology | 1 |
| Peking University | 1 |
| Second Affiliated Hospital of Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphatic Metastasis | 20 |
| Breast Neoplasms | 3 |
| Neoplasm Metastasis | 2 |
| Neoplasms, Unknown Primary | 2 |
| Pancreatic Neoplasms | 2 |
| Thyroid Cancer, Papillary | 2 |
| Carcinogenesis | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.